Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction

螺内酯 医学 危险系数 心房颤动 心力衰竭 内科学 心脏病学 射血分数 随机化 置信区间 随机对照试验
作者
Maja Čikeš,Brian Claggett,Amil M. Shah,Akshay S. Desai,Eldrin F. Lewis,Sanjiv J. Shah,Inder S. Anand,Eileen O’Meara,Jean L. Rouleau,Nancy K. Sweitzer,James C. Fang,Sanjeev Saksena,Bertram Pitt,Marc A. Pfeffer,Scott D. Solomon
出处
期刊:Jacc-Heart Failure [Elsevier BV]
卷期号:6 (8): 689-697 被引量:79
标识
DOI:10.1016/j.jchf.2018.05.005
摘要

This study assessed the relationship between atrial fibrillation (AF) and outcomes in the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) trial, to evaluate whether AF modified the treatment response to spironolactone and whether spironolactone influenced post-randomization AF.AF is common in heart failure with preserved ejection fraction (HFpEF) and likely contributes to increased risk of adverse outcomes.A total 1,765 patients enrolled in TOPCAT trial in North and South America were divided into 3 groups: no known AF, history of AF without AF at enrollment, and AF found on the electrocardiogram (ECG) at enrollment. We assessed outcomes and treatment response to spironolactone in all groups, and the association between post-randomization AF and outcomes in patients free of AF at baseline. The primary outcome of the TOPCAT trial was a composite of cardiovascular mortality, aborted cardiac arrest, or heart failure hospitalization.A total of 760 patients (43%) had a history of AF (18%) or AF on ECG at enrollment (25%). The highest adjusted risk was associated with AF at enrollment (primary outcome, hazard ratio: 1.34; 95% confidence interval: 1.09 to 1.65; p = 0.006; and an increased early risk of secondary outcomes). Neither history of AF nor AF at enrollment modified the beneficial treatment effect of spironolactone. Post-randomization AF, which occurred in 6.3% of patients, was not influenced by spironolactone treatment, but was associated with an increased early risk of the primary outcome (hazard ratio: 2.32; 95% confidence interval: 1.59 to 3.40; p < 0.0001) and secondary outcomes.AF at enrollment was associated with increased cardiovascular risk in HFpEF patients in the TOPCAT study. Post-randomization AF, which was associated with an increased risk of morbidity and mortality, was not influenced by spironolactone. (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist [TOPCAT]; NCT00094302).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
杨春天发布了新的文献求助10
1秒前
汉堡包应助milv5采纳,获得10
1秒前
科研通AI5应助魁梧的曼凡采纳,获得10
3秒前
3秒前
会发光的星星完成签到,获得积分10
6秒前
6秒前
py999发布了新的文献求助10
6秒前
chrissylaiiii发布了新的文献求助30
7秒前
7秒前
Zlinco完成签到,获得积分10
9秒前
11秒前
12秒前
13秒前
如沐春风发布了新的文献求助10
14秒前
萨柏斯塔完成签到,获得积分10
14秒前
milv5发布了新的文献求助10
15秒前
py999完成签到,获得积分10
15秒前
15秒前
wanci应助枯藤老柳树采纳,获得10
16秒前
小蘑菇应助陈cf77采纳,获得10
16秒前
万能图书馆应助陈cf77采纳,获得10
16秒前
科研通AI5应助陈cf77采纳,获得10
16秒前
科研通AI5应助陈cf77采纳,获得10
16秒前
科研通AI5应助陈cf77采纳,获得10
16秒前
今后应助陈cf77采纳,获得10
17秒前
简单完成签到,获得积分10
17秒前
冷傲天川发布了新的文献求助10
17秒前
hy完成签到,获得积分20
17秒前
铁布衫金钟罩完成签到,获得积分10
19秒前
cxh完成签到,获得积分10
19秒前
20秒前
adi完成签到,获得积分10
20秒前
20秒前
20秒前
简单发布了新的文献求助10
23秒前
JamesPei应助如沐春风采纳,获得10
24秒前
JamesPei应助711采纳,获得10
24秒前
杨春天完成签到,获得积分10
25秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Ophthalmic Equipment Market 1500
Neuromuscular and Electrodiagnostic Medicine Board Review 1000
こんなに痛いのにどうして「なんでもない」と医者にいわれてしまうのでしょうか 510
いちばんやさしい生化学 500
The First Nuclear Era: The Life and Times of a Technological Fixer 500
Unusual formation of 4-diazo-3-nitriminopyrazoles upon acid nitration of pyrazolo[3,4-d][1,2,3]triazoles 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3672805
求助须知:如何正确求助?哪些是违规求助? 3228883
关于积分的说明 9782581
捐赠科研通 2939308
什么是DOI,文献DOI怎么找? 1610843
邀请新用户注册赠送积分活动 760758
科研通“疑难数据库(出版商)”最低求助积分说明 736203